Author: Vivacel360 Team
Curcumin is a natural polyphenol from the plant Curcuma longa and is one of the most studied compounds in turmeric. It is studied in laboratory and clinical research for its interaction with processes related to oxidative stress, inflammatory signaling pathways, metabolism, and other biological functions.
However, curcumin has one major problem: what we ingest is not necessarily what our body can effectively utilize.
Classic curcumin is poorly water-soluble, is limited in its absorption from the digestive tract, and is metabolized and eliminated relatively quickly after absorption. As a result, the concentration of free curcumin that can be found in the blood after oral intake often remains very low. [1,2]
This is precisely why much of the research in recent years has focused not only on the question of how much curcumin we take, but also in what form we take it.
What does bioavailability actually mean?
Bioavailability describes how much of an ingested substance becomes available to the body after administration, or how much we can detect in the systemic circulation and over what period.
For two capsules that contain the same amount of curcumin on the label, the body's actual exposure to curcumin does not have to be equal.
The reason lies in the physical and chemical properties of the compound itself.
Curcumin is highly lipophilic, meaning it binds better to fats than to water. Since the digestive tract is predominantly an aqueous environment, this makes its dispersion and absorption difficult. After passing through the intestinal wall, a large part of the curcumin undergoes additional conjugation processes, such as glucuronidation and sulfation. [1,3]
Therefore, increasing bioavailability has become one of the key areas of research in modern curcumin formulations.
What are liposomes?
We can think of liposomes as extremely small structures made of phospholipids.
Phospholipids are interesting because one part of their molecule has an affinity for water, while the other has an affinity for fats. When in the appropriate environment, they can organize into lipid bilayer structures similar to those found in biological membranes.
This makes them interesting carriers of various active compounds.
For lipophilic molecules like curcumin, the goal is to increase their dispersibility in the digestive tract, protect them as they pass through the gastrointestinal environment, and create conditions that can increase their absorption. [1,2]
In other words, the idea is not necessarily to use more curcumin, but to deliver the ingested curcumin more effectively.
And what is proliposomal, or dry liposomal powder?
In dietary supplements, the development of so-called proliposomal systems is particularly interesting.
Unlike a classic liquid liposomal dispersion, a proliposomal system can be produced as a dry powder designed to reorganize into lipid structures upon contact with water or gastrointestinal fluids.
This approach can be technologically interesting because it allows the lipid system to be used within capsules and potentially offers greater stability during storage compared to some liquid dispersions.
However, there is an important scientific nuance here: the word "liposomal" itself is not proof of increased bioavailability.
The result depends on many factors, including the phospholipid composition, particle size, manufacturing method, formulation stability, degree of encapsulation, and the formulation's behavior after passing through the digestive tract.
How much can liposomal technology actually increase absorption?
This is where the science becomes particularly interesting.
The results do not show a single universal value such as "5 times" or "10 times".
For example, in a randomized crossover study of the phospholipid complex of Meriva® curcumin, the total absorption of curcuminoids was approximately 29 times higher than after a comparative non-formulated mixture of curcuminoids. It is important to emphasize that Meriva is not a classic liposome, but a complex of curcuminoids and phosphatidylcholine, and that researchers mainly detected curcuminoid metabolites in the blood. [4]
On the other hand, a randomized crossover study from 2021 compared several different curcumin delivery technologies, including liposomes, micellar systems, phytosomes, and cyclodextrin complexes. In that study, the greatest increase in systemic exposure was recorded with the micellar formulation and the complex with γ-cyclodextrin, while the tested liposomal formulation itself did not show a statistically significant increase compared to native curcumin. [5]
A newer randomized clinical study published in 2026 examined a specific double-layered nano-liposomal formulation in healthy men. After adjusting to the ingested dose, the area under the plasma concentration curve, or AUC, was approximately 23 times higher, and the maximum plasma concentration was more than 50 times higher than with conventional curcumin. However, this was a small study of 18 participants, and the result applies specifically to that formulation, not automatically to every product labeled as liposomal curcumin. [6]
So, is liposomal curcumin absorbed 5–10 times better?
There is no single scientifically supported figure that can be applied to all liposomal formulations.
Depending on the technology, studies have recorded very different values, from no significant improvement to many times higher systemic exposure.
This is why, when making claims about bioavailability, it is more important to ask:
What specific formulation was studied?
rather than just:
Is the product liposomal?
This is an important difference between a marketing claim and pharmacokinetic evidence.
Why is greater bioavailability important at all?
If a certain formulation succeeds in increasing absorption, the same oral dose can potentially result in greater systemic exposure to curcumin or its metabolites.
This is particularly relevant because much of curcumin's biological activity has been identified in experimental models, while its poor oral bioavailability is one of the main reasons why laboratory research results cannot easily be translated to humans.
But greater absorption does not automatically mean a proportionally greater health effect.
Pharmacokinetics tells us how much of a substance is available to the body. Clinical efficacy answers a different question: does that substance meaningfully change a specific health outcome?
This requires separate clinical studies.
Curcumin and inflammatory processes
One of the most studied areas of curcumin is its connection to inflammatory signaling pathways.
Large analyses of randomized clinical trials show that curcumin supplementation in certain populations can affect some biomarkers related to inflammation and oxidative stress. A meta-analysis of more than 100 randomized studies, for example, found statistically significant changes in some parameters, including C-reactive protein. [7]
However, this is not the same as claiming that curcumin "cures inflammation" or a specific inflammatory disease.
In osteoarthritis, there are promising results related to pain and joint function, but the American National Center for Complementary and Integrative Health still states that higher-quality research is needed before final conclusions can be drawn. [8]
What about the brain and cognitive function?
Curcumin is also being intensively studied in the field of neurobiology.
Preclinical research shows several potentially interesting mechanisms, including interaction with oxidative and inflammatory processes. However, the results in humans are not consistent enough to claim that curcumin generally "protects the brain" or improves cognitive abilities.
Some meta-analyses report improvements in individual domains such as working memory, while others find no significant change in overall cognitive function. [9]
Therefore, the claim that "liposomes help curcumin cross the blood-brain barrier" should not be used as a general clinical claim without evidence for a specific formulation.
More is not always better
Increased bioavailability generally sounds like an advantage, but there is another side to the story.
If a technology significantly increases systemic exposure to an active substance, then safety, dosage, and potential side effects must also be considered.
The NCCIH states that conventional turmeric and curcumin preparations can cause digestive side effects such as nausea, reflux, diarrhea, or constipation. Rare cases of liver damage related to some high-bioavailability preparations have also been reported, which is why "greater absorption" should not be viewed as synonymous with "the more, the better".
Science beyond the number on the label
Curcumin is a good example of how far modern nutritional science has gone beyond the simple question of how many milligrams of an ingredient a product contains.
For compounds with naturally poor solubility and limited oral bioavailability, the delivery method can be just as important as the amount of active ingredient.
Liposomes, proliposomal powders, phospholipid complexes, micellar systems, and other technologies attempt to solve the same problem using different approaches.
Research clearly shows that curcumin bioavailability can be significantly increased. What science does not support is the assumption that every liposomal formulation will achieve the same result.
Therefore, perhaps the most precise question we can ask is:
Not only "how much curcumin does it contain?", but also "how is that curcumin formulated?"
Related product: Vivacel360 CURCUMIN – a dietary supplement in liposomal form.
Literature and sources
[1] Tabanelli R. et al. Improving Curcumin Bioavailability: Current Strategies and Future Perspectives.Pharmaceutics. 2021;13(10):1715. DOI: 10.3390/pharmaceutics13101715.
[2] Stohs SJ. et al. Highly Bioavailable Forms of Curcumin and Promising Avenues for Curcumin-Based Research and Application: A Review. Molecules. 2020;25(6):1397.
[3] Biomedical Applications and Bioavailability of Curcumin—An Updated Overview. A review of data on curcumin absorption, metabolism, and delivery technologies.
[4] Cuomo J. et al. Comparative Absorption of a Standardized Curcuminoid Mixture and Its Lecithin Formulation.Journal of Natural Products. 2011;74(4):664–669. DOI: 10.1021/np1007262.
[5] Flory S. et al. 10.1002/mnfr.202100613" target="_blank" rel="noopener">Increasing Post-Digestive Solubility of Curcumin Is the Most Successful Strategy to Improve its Oral Bioavailability: A Randomized Cross-Over Trial in Healthy Adults and In Vitro Bioaccessibility Experiments.Molecular Nutrition & Food Research. 2021;65(24):2100613. DOI: 10.1002/mnfr.202100613.
[6] Enhanced bioavailability of a novel double-layered nano-liposomal curcumin (BNT-C060): a randomized, double-blind, clinical trial. Scientific Reports. 2026. DOI: 10.1038/s41598-026-53709-8.
[7] Curcumin on Human Health: A Comprehensive Systematic Review and Meta-Analysis of 103 Randomized Controlled Trials. Phytotherapy Research. Analysis of 103 RCTs and 7,216 participants.
[8] National Center for Complementary and Integrative Health (NCCIH). Turmeric: Usefulness and Safety. An up-to-date review of clinical evidence and the safety of turmeric and curcumin.
[9] Targeting cognitive aging with curcumin supplementation: A systematic review and meta-analysis. A systematic review of preclinical and human studies on cognitive outcomes. 2025.
The content of this article is for informational purposes and does not replace the advice of a doctor or pharmacist. Dietary supplements are not a substitute for a balanced and varied diet and a healthy lifestyle.